Randall Livingston resigned from the Genomic Health Inc. board.
The company did not specify a reason for Livingston's departure in its securities filing.
Discover more about S&P Global’s offerings
Genomic Health board member resigns
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Randall Livingston resigned from the Genomic Health Inc. board.
The company did not specify a reason for Livingston's departure in its securities filing.